PTX3 and adenocarcinoma: Compared with CA/AA, patients with cervical invasive carcinoma with genotype CC in PTX3 rs2120243 had a higher chance of developing adenocarcinoma, but no squamous cell carcinoma (OR for adenocarcinoma: 0.21, 95% CI: 0.05-0.78, CA/AA vs CC; Table 3).